News

Dr. Oz and FDA chief tout industry doing MAHA’s bidding
The Trump administration‘s “Make America Healthy Again” goals depend on negotiations with food and healthcare industry ...
FDA’s artificial intelligence is supposed to revolutionize drug approvals. It’s making up studies
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...
The FDA Just Axed 52 Food Standards. Is That a Good Thing?
It noted that, at the time, there were products "that were represented as jams containing fruit, but the products contained ...
FDA panel on the use of antidepressants during pregnancy is alarming experts
On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...
FDA to review prescription fluoride supplements for kids at risk for tooth decay
The Trump administration is inching closer to banning fluoride tablets and drops often prescribed to kids who don’t have ...
Newsweek on MSN1h
FDA Issues Highest Risk Warning for Tofu Recall
Shang Hao Jia, Inc. issued a voluntary recall for several cases of Danshi Spicy Shredded Tofu due to possible undeclared sesame.
FDA appoints biotech executive as top drug regulator under RFK Jr.
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Biotech exec George Tidmarsh picked as FDA's chief drug regulator
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
Former biotech executive appointed to lead FDA drug review office
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...